Mitochondrial DNA (mtDNA) mutations are responsible for mitochondrial diseases in numerous patients. But, until now, no rapid method was available for the identification of unknown deleterious point mutations. Here, we describe a new strategy for the rapid identification of heteroplasmic mtDNA mutations using mismatch-specific Surveyor Nuclease. This protocol involves the following three steps: (i) PCR amplification of the entire human mitochondrial genome in 17 overlapping fragments; (ii) localization of mtDNA mismatch(es) after digestion of the 17 amplicons by Surveyor Nuclease; and (iii) identification of the mutation by sequencing the region containing the mismatch. This Surveyor Nuclease-based strategy allows a systematic screening of the entire mtDNA to identify a mutation within 2 days. It represents an important diagnostic approach for mitochondrial diseases that can be routinely used in molecular diagnostic laboratories.
Subscribe to Journal
Get full journal access for 1 year
only $41.25 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Anderson, S. et al. Sequence and organization of the mitochondrial human genome. Nature 290, 457–465 (1981).
Wallace, D.C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet. 39, 359–407 (2005).
Dimauro, S. & Schon, E.A. Mitochondrial DNA mutations in human disease. Am. J. Med. Genet. 106, 18–26 (2001).
Barros, F., Lareu, M.V., Salas, A. & Carracedo, A. Rapid and enhanced detection of mitochondrial DNA variation using single-strand conformation analysis of superposed restriction enzyme fragments from polymerase chain reaction-amplified products. Electrophoresis 18, 52–54 (1997).
Sternberg, D. et al. Exhaustive scanning approach to screen all the mitochondrial tRNA genes for mutation and its application to the investigation of 35 independent patients with mitochondrial disorders. Hum. Mol. Genet. 7, 33–42 (1998).
van de Bosch, B.J.C. et al. Mutation analysis of the entire mitochondrial genome using denaturing high performance liquid chromatography. Nucleic Acids Res. 28, e89 (2000).
Biggin, A., Henke, R., Bennetts, B., Thorburn, D.R. & Christodoulou, J. Mutation screening of the mitochondrial genome using denaturing high-performance liquid chromatography. Mol. Genet. Metab. 84, 61–74 (2005).
Bayat, A. et al. Mitochondrial mutation detection using enhanced multiplex denaturing high-performance liquid chromatography. Int. J. Immunogenet. 32, 199–205 (2005).
Wulfert, M., Tapprich, C. & Gattermann Optimized PCR fragments for heteroduplex analysis of the whole human mitochondrial genome with denaturing HPLC. J. Chromatogr. B 831, 236–247 (2006).
Wong, L.J. et al. Comprehensive scanning of the entire mitochondrial genome for mutations. Clin. Chem. 48, 1901–1912 (2002).
Qiu, P. et al. Mutation detection using Surveyor™ nuclease. BioTechniques 36, 702–707 (2004).
Wada, T., Fukushima, Y. & Saitoh, S. A new detection method for ATRX gene mutations using a mismatch-specific endonuclease. Am. J. Med. Genet. A 140, 1519–1523 (2006).
Janne, P.A. et al. A rapid and sensitive enzymatic method for epidermal growth factor receptor mutation screening. Clin. Cancer Res. 12, 751–758 (2006).
Sattler, M. et al. A sensitive high-throughput method to detect activating mutations of Jak2 in peripheral-blood samples. Blood 107, 1237–1238 (2006).
Engelman, J.A. et al. Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer. J. Clin. Invest. 116, 2695–2706 (2006).
Bannwarth, S., Procaccio, V. & Paquis-Flucklinger, V. Surveyor™ nuclease: a new strategy for a rapid identification of heteroplasmic mitochondrial DNA mutations in patients with respiratory chain defects. Hum. Mutat. 25, 575–582 (2005).
Andreasson, A., Asp, A., Alderborn, A., Gyllensten, U. & Allen, M. Mitochondrial sequence analysis for forensic identification using pyrosequencing technology. BioTechniques 32, 124–126 (2002).
Brandon, M., Baldi, P. & Wallace, D.C. Mitochondrial mutations in cancer. Oncogene 25, 4647–4662 (2006).
Trounce, I.A., Kim, Y.L., Jun, A.S. & Wallace, D.C. Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsy, lymphoblasts, and transmitochondrial cell lines. Methods Enzymol. 264, 484–509 (1996).
Kivisild, T. et al. The role of selection in the evolution of human mitochondrial genomes. Genetics 172, 373–387 (2006).
Maniatis, T., Fritsch, E.F. & Sambrook, J. Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 1982).
Moraes, C.T., Ricci, E., Bonilla, E., Dimauro, S. & Schon, E.A. The mitochondrial tRNA(Leu(UUR)) mutation in mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS): genetic, biochemical, and morphological correlations in skeletal muscle. Am. J. Hum. Genet. 50, 934–949 (1992).
We thank B Chafino, A Blombou, S Charabot and A Figueroa for technical help. We also thank F Stefani and N Neckelmann from Transgenomic for helpful discussions. This work was made possible by grants from CHU Nice (CPR UF 699), France.
The authors declare no competing financial interests.
About this article
Cite this article
Bannwarth, S., Procaccio, V. & Paquis-Flucklinger, V. Rapid identification of unknown heteroplasmic mutations across the entire human mitochondrial genome with mismatch-specific Surveyor Nuclease. Nat Protoc 1, 2037–2047 (2006) doi:10.1038/nprot.2006.318
Nature Medicine (2018)
Mitochondrial DNA Part A (2018)
Diff-seq: A high throughput sequencing-based mismatch detection assay for DNA variant enrichment and discovery
Nucleic Acids Research (2018)
Altered circulating mitochondrial DNA and increased inflammation in patients with diabetic retinopathy
Diabetes Research and Clinical Practice (2015)
Colorimetric detection of single nucleotide polymorphisms in the presence of 10 3 - fold excess of a wild-type gene
Biosensors and Bioelectronics (2015)